TLPH Q3 2022 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena

TLPHTalphera, Inc.

$18M

Q3 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$424,000

Operating Income

-$5M

Net Income

-$7M

EPS (Diluted)

$-0.91

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$701,000

Balance Sheet

Total Assets

$48M

Total Liabilities

$21M

Stockholders' Equity

$28M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$2M	-100.0%
Gross Profit	-$424,000	$1M	-135.9%
Operating Income	-$5M	-$9M	+47.6%
Net Income	-$7M	-$8M	+19.4%